Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Soliman

Showing results (371-380 of 424) with videos related to

Pageof 43
Sort By:
ESMO Open|November 12, 2025
Phase I trial of neratinib plus palbociclib in advanced cancers with HER family alterationsS A Piha-Paul, C Tseng, H T Tran, et al.
Brachytherapy|November 1, 2023
Comparing long-term sexual dysfunction across different uterine cancer treatment modalitiesAlison K Yoder, David S Lakomy, Juliana Wu, et al.
Gynecologic Oncology|November 15, 2011
Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task ForcePedro T Ramirez, Sarah Adams, John F Boggess, et al.
American Journal of Obstetrics and Gynecology|August 25, 2020
Endometrial biomarkers in premenopausal women with obesity: an at-risk cohortJoseph A Dottino, Qian Zhang, David S Loose, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|August 26, 2022
Update on MRI in Evaluation and Treatment of Endometrial CancerEkta Maheshwari, Stephanie Nougaret, Erica B Stein, et al.
ESMO Open|February 5, 2025
Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterationsS A Piha-Paul, C Tseng, H T Tran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologistsJvan Casarin, Francesco Multinu, Nadeem Abu-Rustum, et al.
Gynecologic Oncology|February 23, 2025
Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progressionAmma Asare, Rebecca Ann Previs, Daniel Spinosa, et al.
Pediatric Endocrinology Reviews : PER|May 13, 2015
Selected highlights of the VIII International Symposium of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine (ICET-A) on Growth, Puberty and Endocrine Complications in Thalassaemia. Auditorium of the Sultan Qaboos University (SQU) Muscat (Sultanate of Oman), 20th of December 2014Vincenzo De Sanctis, Ashraf T Soliman, Yasser Wali, et al.
Medicine|June 17, 2022
Hematological indices reference intervals for a healthy Arab population in Qatar: Effect of age, gender, and geographic locationMohamed A Yassin, Ashraf T Soliman, Abdulqadir J Nashwan, et al.
Pageof 43

Showing results (371-380 of 424) with videos related to

Sort By:
Pageof 43
ESMO Open|November 12, 2025
Phase I trial of neratinib plus palbociclib in advanced cancers with HER family alterationsS A Piha-Paul, C Tseng, H T Tran, et al.
Brachytherapy|November 1, 2023
Comparing long-term sexual dysfunction across different uterine cancer treatment modalitiesAlison K Yoder, David S Lakomy, Juliana Wu, et al.
Gynecologic Oncology|November 15, 2011
Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task ForcePedro T Ramirez, Sarah Adams, John F Boggess, et al.
American Journal of Obstetrics and Gynecology|August 25, 2020
Endometrial biomarkers in premenopausal women with obesity: an at-risk cohortJoseph A Dottino, Qian Zhang, David S Loose, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|August 26, 2022
Update on MRI in Evaluation and Treatment of Endometrial CancerEkta Maheshwari, Stephanie Nougaret, Erica B Stein, et al.
ESMO Open|February 5, 2025
Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterationsS A Piha-Paul, C Tseng, H T Tran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologistsJvan Casarin, Francesco Multinu, Nadeem Abu-Rustum, et al.
Gynecologic Oncology|February 23, 2025
Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progressionAmma Asare, Rebecca Ann Previs, Daniel Spinosa, et al.
Pediatric Endocrinology Reviews : PER|May 13, 2015
Selected highlights of the VIII International Symposium of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine (ICET-A) on Growth, Puberty and Endocrine Complications in Thalassaemia. Auditorium of the Sultan Qaboos University (SQU) Muscat (Sultanate of Oman), 20th of December 2014Vincenzo De Sanctis, Ashraf T Soliman, Yasser Wali, et al.
Medicine|June 17, 2022
Hematological indices reference intervals for a healthy Arab population in Qatar: Effect of age, gender, and geographic locationMohamed A Yassin, Ashraf T Soliman, Abdulqadir J Nashwan, et al.
Pageof 43